Related Experiment Videos

Cardiac consequences of the systemic lupus erythematosus therapy with corticosteroids morphological study

Cătălina Arsenescu1, Doina Butcovan, M Rotar

  • 1School of Medicine, Medical Cardiology-Cardiology Center, University of Medicine and Pharmacy Gr.T. Popa, Iaşi.

Revista Medico-Chirurgicala a Societatii De Medici Si Naturalisti Din Iasi
|February 21, 2004
PubMed

Insights

Systemic lupus erythematosus (SLE) therapy can cause cardiac issues. A patient with SLE developed a right ventricular mass, histologically confirmed as a thrombotic mass, potentially linked to her treatment and pulmonary hypertension.

Area of Science:

  • Cardiology
  • Rheumatology
  • Pathology

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease with potential cardiac manifestations.
  • Therapies for SLE, including prednisone and cyclophosphamide, carry known risks.
  • Cardiac complications in SLE patients require thorough investigation.

Observation:

  • A 50-year-old female with a history of SLE presented with right decompensated heart disease.
  • Imaging revealed an apical right ventricular mass obstructing the cavity.
  • Pulmonary hypertension was also noted in the patient.

Findings:

  • Endomyocardial biopsy confirmed the mass as an organizing thrombotic structure.
  • Histological analysis indicated the mass formed within a dilated right ventricle.
  • The findings suggest a link between SLE, its treatment, and cardiac morphology alterations.

Implications:

  • This case highlights the potential for severe cardiac complications in SLE patients.
  • Drug-induced cardiotoxicity and thrombotic events should be considered in SLE management.
  • Understanding these adverse effects is crucial for optimizing patient care and outcomes.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...